Riskpilot← Back to searchSign inGet full accessCelgene AB
ABDissolvedOrg 5567042410Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200617 employees
Revenue 2022
SEK 326,2M
-59% vs 2021
EBITDA margin
5.1%
-52% vs 2021
Equity ratio
77.4%
Financial strength
Net profit 2022
SEK 13,1M
-52% vs 2021
| Revenue | SEK 326,2M | -59% |
| EBITDA | SEK 16,7M | -52% |
| Net profit | SEK 13,1M | -52% |
| Total assets | SEK 144,5M | -63% |
| Equity | SEK 111,8M | -44% |
| Employees | 17 | — |
Legal name
Celgene AB
Org number
5567042410
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17 maj 2006
Share capital
SEK 2 000 000
Employees
17 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva forskning, utveckling, marknadsföring och försäljning av läkemedel samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 772 529 | 953 602 | 930 208 | 786 708 | 326 172 |
| Staff expenses | — | — | — | — | — | — | — | — |
| EBITDA | 32 223 | 21 430 | 31 912 | 35 958 | 36 753 | 51 672 | 34 872 | 16 739 |
| Depreciation & amort. | −801 | −960 | −956 | −1 071 | −1 033 | −2 533 | −0 | −0 |
| EBIT | 31 422 | 20 470 | 30 956 | 34 887 | 35 720 | 49 139 | 34 872 | 16 739 |
| Net financials | −35 | −125 | 361 | −939 | 1 492 | — | −36 | 56 |
| Profit before tax | 31 386 | 20 345 | 31 317 | 33 948 | 37 211 | 49 139 | 34 836 | 16 794 |
| Tax | −7 307 | −5 246 | −9 524 | −9 916 | −9 593 | −11 306 | −7 675 | −3 690 |
| Net profit | 24 079 | 15 099 | 21 793 | 24 032 | 27 618 | 37 833 | 27 161 | 13 104 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 110 331 | 126 012 | 187 205 | 251 916 | 352 732 | 376 095 | 388 508 | 144 543 |
| Equity | 45 181 | 60 280 | 82 074 | 106 105 | 133 723 | 171 556 | 198 717 | 111 821 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 65 150 | 65 732 | 105 131 | 145 811 | 219 009 | 204 539 | 189 791 | 32 721 |
| Total debt | 65 150 | 65 732 | 105 131 | 145 811 | 219 009 | 204 539 | 189 791 | 32 721 |
EBITDA margin
5.1%
This company
15.8%
Market median
-68% vs market
20152022
Equity ratio
77.4%
This company
38.2%
Market median
+103% vs market
20152022
Return on equity
11.7%
This company
18.4%
Market median
+36% vs market
20152022
Net profit margin
4.0%
This company
8.1%
Market median
-51% vs market
20152022
Asset turnover
2.26×
This company
1.12×
Market median
+102% vs market
20152022
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20152022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JG Chief Auditor | Chief Auditor | 2020 | — | — |
PF Chief Auditor | Chief Auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Celegne Netherlands B.V. | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Celegne Netherlands B.V.
Celgene AB (this company)Board members of Celgene AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jimmy Gustav Almqvist | Chief Auditor | 0 companies |
| Petter Fredrik Engdahl | Chief Auditor | 0 companies |
| David Walter Pignolet | Board of Directors | 0 companies |
| Björn Ingemar Hellström | Board of Directors | 0 companies |
| Michaël Guislain Lugez | Chairman | 0 companies |
| Swati Mehta | Board of Directors | 0 companies |
| Anna Katarina Edsfors Åleskog | Deputy Board Member | 0 companies |
| Abdelhamid Chaâïbi | Board of Directors | 0 companies |
| Stephane Jacques C. Strebelle | Board of Directors | 0 companies |
| Tuomo Tapani Pätsi | Chairman | 0 companies |
| Jörg Boris Schulze | Chairman | 0 companies |
| Iddo Leshem | Board of Directors | 0 companies |